Literature DB >> 9635626

Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association.

S Parveen1, S A Morshed, K Arima, M Nishioka, A J Czaja, W C Chow, H S Ng.   

Abstract

To assess whether demography is one of the important factors determining antibody response to nuclear antigens [ANA: SSA-Ro (52K and 60K), SSB-La, snRNPs (A, 70K, B'/B), and Cenp-B], we investigated 95 and 47 sera of autoimmune hepatitis (AIH) from North America and Asia, respectively, by immunofluorescent (IF) and recombinant ELISA. Correlations among nuclear IF patterns, ELISA, and disease indices were analyzed. The frequency and titer of individual antibodies differed significantly between the groups. Patients with speckled patterns were younger in both regions and had higher aspartate aminotransferase levels only in North America. HLA-A1, B8, DQ2, and DR4 or DR3 or both in North America, and A2, B61, DQ7, and DR4 in Asia were predominant. In Asia, B61 correlated with anti-70K, and DQ7 correlated with antibodies to 52K, Cenp-B, and B'/B. In North America, A1, B8, DR3 haplotype, and DQ2 correlated with antibodies to A and 70K. Anti-B'/B and DR4 in North America, and A2 in Asia, were associated with concurrent immunologic disorder. Individual ANA clusters correlated with individual HLA in the demography, and different HLA alleles might determine disease expression as well as different ANA being produced in AIH.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635626     DOI: 10.1023/a:1018880429469

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

Review 1.  Rheumatoid arthritis: inheritance and association with other autoimmune diseases.

Authors:  D M Grennan; P A Sanders; W Thomson; P A Dyer
Journal:  Dis Markers       Date:  1986-06       Impact factor: 3.434

Review 2.  Clinical significance and interpretation of antinuclear antibodies.

Authors:  R H White; D L Robbins
Journal:  West J Med       Date:  1987-08

Review 3.  Human autoantibodies: probes for nucleolus structure and function.

Authors:  G Reimer; I Raska; E M Tan; U Scheer
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1987

Review 4.  Antinuclear antibodies as molecular and diagnostic probes.

Authors:  S Whittingham; L J McNeilage
Journal:  Mol Cell Probes       Date:  1988-09       Impact factor: 2.365

5.  Meeting report: International Autoimmune Hepatitis Group.

Authors:  P J Johnson; I G McFarlane
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

6.  Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.

Authors:  P T Donaldson; D G Doherty; K M Hayllar; I G McFarlane; P J Johnson; R Williams
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

7.  mRNA polyadenylate-binding protein: gene isolation and sequencing and identification of a ribonucleoprotein consensus sequence.

Authors:  S A Adam; T Nakagawa; M S Swanson; T K Woodruff; G Dreyfuss
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

8.  Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions.

Authors:  R L Slobbe; W Pluk; W J van Venrooij; G J Pruijn
Journal:  J Mol Biol       Date:  1992-09-20       Impact factor: 5.469

9.  Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.

Authors:  A J Czaja; J Rakela; J E Hay; S B Moore
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

10.  Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome.

Authors:  J B Harley; M Reichlin; F C Arnett; E L Alexander; W B Bias; T T Provost
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

View more
  8 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 2.  Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2017-07-14       Impact factor: 3.199

Review 3.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

4.  Frequency and significance of antibodies to chromatin in autoimmune hepatitis.

Authors:  Albert J Czaja; Zakera Shums; Walter L Binder; Stephen J Lewis; Vicki J Nelson; Gary L Norman
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

Review 5.  Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.

Authors:  Edward K L Chan
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 10.817

6.  Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.

Authors:  Kalliopi Zachou; Eirini Rigopoulou; George N Dalekos
Journal:  J Autoimmune Dis       Date:  2004-10-15

Review 7.  Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease.

Authors:  Nikhil Kapila; Jennifer T Higa; Maria Serena Longhi; Simon C Robson
Journal:  J Clin Transl Hepatol       Date:  2013-12-15

Review 8.  Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.

Authors:  Marcial Sebode; Christina Weiler-Normann; Timur Liwinski; Christoph Schramm
Journal:  Front Immunol       Date:  2018-03-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.